Systematic review of interventions in the management of overweight and obese children which include a dietary

Clare E Collins1, Janet M Warren, Melinda Neve

  • 11The Australian Centre for Evidence Based Nutrition and Dietetics: a collaborating centre of the Joanna Briggs Institute, 2. School of Health Sciences and 3. Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia.

JBI Library of Systematic Reviews
|November 8, 2016
PubMed

Insights

Effective pediatric obesity treatment requires evidence-based dietary interventions. Current research highlights a need for high-quality studies with long-term follow-up to guide best practices in managing childhood overweight and obesity.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Evidence-Based Medicine

Background:

  • Rising global rates of overweight and obesity in children and adolescents necessitate effective public health strategies.
  • Evidence-based management is crucial to reduce obesity-related health risks.
  • Diet is a key factor in obesity treatment, yet optimal approaches lack clear definition.

Purpose of the Study:

  • To identify and synthesize the best available evidence on optimal dietary interventions for overweight and obese children and adolescents.
  • To inform clinical practice with effective, evidence-based dietary management strategies.

Main Methods:

  • Comprehensive literature search of multiple electronic databases (1975-2003) and grey literature.
  • Inclusion criteria focused on dietary interventions for overweight/obese individuals under 18.
  • Rigorous study selection, critical appraisal, and data extraction processes were employed.

Main Results:

  • 116 articles met inclusion criteria, including randomized controlled trials and non-randomized trials.
  • Dietary interventions generally showed short-term weight loss, but study quality was often poor.
  • High heterogeneity and inadequate reporting of dietary details hindered comparisons and replication.

Conclusions:

  • Urgent need for high-quality research on optimal pediatric obesity dietary management.
  • Future studies must include adequate long-term follow-up to assess sustained weight loss.
  • Detailed reporting of dietary prescriptions, adherence, and outcomes is essential for evidence-based practice.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
994
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342